Ireland-Based Felixvet Plans Briarcliff, Missouri, North American Headquarters
07/14/2023
The new office will serve as the center to support commercial and regulatory operations throughout the U.S. and Canada.
"We are confident that Felixvet is poised to become one of the leading companion animal generic drug companies globally," said Vince Palasota, president of North America at Felix. "With our extensive pipeline, quick response capabilities and deep understanding of ANADA and brand competition strategies, we believe the veterinarian and marketing partners will recognize the significant value-added benefits we bring to the table."
Felix develops bio-equivalent generic pharmaceutical products for companion animals upon patent expiry. The company’s initial focus is to market and distribute these products in the U.S., upon approval by the Food and Drug Administration.
“We are proud to welcome Felixvet, a business committed to advancing animal health through high-quality pharmaceuticals, to the Kansas City region,” noted Kimberly Young, president of the KC Animal Health Corridor. “Here, Felix will enjoy proximity to many of their industry clients who call the KC Animal Health Corridor home, as well as abundant access to distribution resources and a robust animal health industry network."
Project Announcements
Japan-Based TOCALO Plans Chandler, Arizona, Operations
04/17/2026
Dakota Bodies Expands Liberty, Missouri, Operations
04/17/2026
Linde Plans Garysburg, North Carolina, Air Separation Operations
04/17/2026
Netherlands-Based Signature Foods USA Plans Easley, South Carolina, Manufacturing Operations
04/16/2026
Lumber Liquidators Plans Lawrenceburg, Tennessee, Headquarters Operations
04/16/2026
Canada-Based Bioriginal Food & Science Plans Grand Junction, Colorado, Operations
04/15/2026
Most Read
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026
-
Where Workforce Capacity Is Being Built — and Where It’s Being Deployed
Q1 2026
-
Advanced Manufacturing Isn’t a Buzzword—It’s a Different Location Strategy
Q1 2026